Form D · Venture Capital Fund

ONCOLOGY VENTURES FUND I LP

New York, NY · CIK 0001975143

Offering snapshot reported May 14, 2024 · SEC filing

Reported sold: $21.2M
Investors reported: 69
Minimum accepted: $10K
First sale: Apr 28, 2023

What changed?

Latest filing versus its linked predecessor, where available.

Reported investors0 → 69
Minimum accepted$0 → $10,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 14, 2024	Amendment	$21,162,000	No comparison	69	SEC filing
Apr 25, 2023	Initial	Yet to sell	No comparison	0	SEC filing
Apr 25, 2023	Amendment	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-479913

Source: Form D, filed May 14, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ONCOLOGY VENTURES FUND I LP

Investment adviser: ONCOLOGY VENTURES LLC

Gross asset value: $25.4M
Beneficial owners: 75
ADV minimum commitment: $0

Reported in Form ADV on Feb 25, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator VECTOR AIS SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor HILL, BARTH & KING LLC MELVILLE, New York, United States

Custodian CHARLES SCHWAB & CO., INC. OMAHA, Nebraska, United States Related to adviser: No

Custodian JPMORGAN CHASE & CO. NEWARK, Delaware, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

HILL, BARTH & KING LLC
PCAOB 2206

Filing source

Form ADV 2058141 · Feb 25, 2026 · Schedule D 7.B.(1), fund 805-7842651374

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
ONCOLOGY VENTURES FUND I LP (this fund)	May 14, 2024	$21,162,000	69
Oncology Ventures Fund II LP	Mar 19, 2026	$42,320,000	99

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Ben Freeberg	Executive
N/A Oncology Ventures Gp I Llc	Executive
N/A Oncology Ventures Llc	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

C/O Oncology Ventures Gp I Llc 160 East 38 Th Street, Unit 24 C
New York, NY, 10002